Sonoma Pharmaceuticals Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $3.39M Miss $3.94M Estimate
Sonoma Pharmaceuticals Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $3.39M Miss $3.94M Estimate
Sonoma Pharmaceuticals第一季度每股收益为$(0.07)，低于$(0.06)的预期，销售额为339万美元，低于394万美元的预期。
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 75.86 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $3.39 million which missed the analyst consensus estimate of $3.94 million by 13.93 percent. This is a 1.05 percent decrease over sales of $3.43 million the same period last year.
Sonoma Pharmaceuticals（纳斯达克SNOA）报告季度每股亏损0.07美元，未达到分析师预期的0.06美元，下降了16.67%。与去年同期每股亏损0.29美元相比，这是一个增长了75.86%的数字。该公司报告季度销售额339万美元，未达到分析师预期的394万美元，下降了13.93%。与去年同期的销售额343万美元相比，这是一个1.05%的降幅。